The sudden retirement of Chief Executive Davinder Brar has set off speculation in some corners that Tempest, a nine-year company veteran, is just warming the seat for MalvinderSingh, the founder's grandson.
"The intrinsic India story of fantastic demographics and a growing economy remains intact, " says MalvinderSingh, chairman of Ranbaxy Laboratories, the giant pharmaceutical firm, who argues that the domestic market is big enough to support growth.